AREV Life Sciences Global Corp.
AREVF
$0.01
$0.005100.00%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -21.60K | -89.90K | -125.20K | 58.60K | -184.40K |
| Total Depreciation and Amortization | 10.30K | 10.30K | 10.20K | 21.20K | 24.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 700.00 | 700.00 | 57.70K | -170.30K | 26.40K |
| Change in Net Operating Assets | 6.40K | -7.30K | 38.80K | 86.80K | 139.70K |
| Cash from Operations | -4.20K | -86.20K | -18.50K | -3.70K | 6.60K |
| Capital Expenditure | -- | -- | -- | 9.00K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -10.10K | -- |
| Cash from Investing | -- | -- | -- | -1.10K | 0.00 |
| Total Debt Issued | 0.00 | 83.90K | 32.70K | -8.60K | 9.00K |
| Total Debt Repaid | -- | -- | -- | -- | -13.70K |
| Issuance of Common Stock | 0.00 | 0.00 | 31.50K | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 62.50K | 47.50K | -6.30K | -3.60K |
| Foreign Exchange rate Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.20K | -23.70K | 29.00K | -11.10K | 3.00K |
